haloperidol
Generic: haloperidol
Labeler: mylan institutional inc.Drug Facts
Product Profile
Brand Name
haloperidol
Generic Name
haloperidol
Labeler
mylan institutional inc.
Dosage Form
TABLET
Routes
Active Ingredients
haloperidol 2 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51079-735
Product ID
51079-735_3dd4fea4-d455-5a4d-e063-6394a90ab14c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA070278
Listing Expiration
2026-12-31
Marketing Start
2004-02-15
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51079735
Hyphenated Format
51079-735
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
haloperidol (source: ndc)
Generic Name
haloperidol (source: ndc)
Application Number
ANDA070278 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
Packaging
- 100 BLISTER PACK in 1 CARTON (51079-735-20) / 1 TABLET in 1 BLISTER PACK (51079-735-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3dd4fea4-d455-5a4d-e063-6394a90ab14c", "openfda": {"nui": ["N0000180182"], "unii": ["J6292F8L3D"], "rxcui": ["310670", "310671", "310672", "314034", "314035"], "spl_set_id": ["ad7d2f17-a4e8-4ebc-9baf-5983ac626782"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (51079-735-20) / 1 TABLET in 1 BLISTER PACK (51079-735-01)", "package_ndc": "51079-735-20", "marketing_start_date": "20040215"}], "brand_name": "Haloperidol", "product_id": "51079-735_3dd4fea4-d455-5a4d-e063-6394a90ab14c", "dosage_form": "TABLET", "pharm_class": ["Typical Antipsychotic [EPC]"], "product_ndc": "51079-735", "generic_name": "haloperidol", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Haloperidol", "active_ingredients": [{"name": "HALOPERIDOL", "strength": "2 mg/1"}], "application_number": "ANDA070278", "marketing_category": "ANDA", "marketing_start_date": "20040215", "listing_expiration_date": "20261231"}